Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?

American Journal of Hypertension

Volumn 16, Issue 4, 2003, Pages 297-301

  Bur, Andreas ^a   Herkner, Harald ^a   Woisetschläger, Christian ^a   Vlcek, Marianne ^a   Derhaschnig, Ulla ^a   Hirschl, Michael M ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Diabetes; Fasting plasma glucose; Glycosylated hemoglobin; Hypertension; Oral glucose tolerance test; Screening

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; AUSTRIA; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 0037381521     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03273-9     Document Type: Article

References (29)

1. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease and nephropathy. Hypertension 1995;26:869-879.
2. Cignarelli M, De Cicco ML, Damato A, Paternostro A, Pagliarini S, Santoro S, Cardia L, De Pergola G, Giorgino R: High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992;15:1002-1008.
3. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ: Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990;120:672-676.
4. 1999 World Health Organization-International Society of Hypertension guidelines for the management of Hypertension. J Hypertens 1999;17:151-183.
5. Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446.
6. Hypertension in Diabetes Study Group: Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-317.
7. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, the LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
8. Kjeldsen SE, Julius S, Brunner H, Hansson L, Henis M, Ekman S, Laragh J, McInnes G, Smith B, Weber M, Zanchetti A: Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. Blood Press 2001;10:83-91.
9. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
10. De Vegt F, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: The 1997 American Diabetes Association criteria versus the 1985 World Health Diabetes Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 1998;21:1686-1690.
11. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez-Jauregui J, Guillen-Pineda LE, Rull JA: Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998;21:1886-1888.
12. Gimeno SGA, Ferriera SRG, Franco LJ, Iunes M, the Japanese-Brazilian Diabetes Study Group: Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group. Diabetes Care 1998;21:1889-1892.
13. Hanson RL, Nelson RG, McCance DR, Beart JR, Charles MA, Pettitt DJ, Knowler WC: Comparison of screening test for non-insulin-dependent diabetes mellitus. Arch Intern Med 1993;53:2133-2140.
14. Forrest RD, Jackson CA, Yudkin JS: The glycohaemoglobin assay as a screening test for diabetes mellitus: the Islington Diabetes Survey. Diabet Med 1987;4:254-259.
15. Mancia G, Sega R, Bravi C, De-Vito G, Valagussa F, Cesana G, Zanchetti A: Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995;13:1377-1390.
16. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ: Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-2470.
17. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994;23:145-158.
18. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J: Effect of diuretic-based antihypertensive treatment on cardiovascular risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-1892.
19. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study. Arch Intern Med 1996;156:286-289.
20. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioll M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996;45:216-222.
21. Agewall S: Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose? J Hum Hypertens 2001;15:71-74.
22. Decode-study group on behalf of the European Diabetes Epidemiology Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999;42:647-654.
23. Nelson RL. Oral glucose tolerance test. Indications and limitations. Mayo Clin Proc 1988;263-269.
24. Ko GTC, Chan JCN, Woo J, Lau E, Yeung VTF, Chow Ch-Ch, Cockram CS: The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998;35:62-67.
25. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE: Reproducibility and comperative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978;27:715-725.
26. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE: Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000;23:278-282.
27. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997;20:1859-1862.
28. Harris MI: Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998;21(Suppl 3):C11-C14.
29. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524.